180 related articles for article (PubMed ID: 22410447)
1. Relationship between mitochondria and α-synuclein: a study of single substantia nigra neurons.
Reeve AK; Park TK; Jaros E; Campbell GR; Lax NZ; Hepplewhite PD; Krishnan KJ; Elson JL; Morris CM; McKeith IG; Turnbull DM
Arch Neurol; 2012 Mar; 69(3):385-93. PubMed ID: 22410447
[TBL] [Abstract][Full Text] [Related]
2. Variable expression of mitochondrial complex IV in the course of nigral intracellular accumulation of α-synuclein.
Lang A; Dassler E; Milenkovic I; Lutz MI; Kovacs GG
Parkinsonism Relat Disord; 2021 Sep; 90():57-61. PubMed ID: 34385008
[TBL] [Abstract][Full Text] [Related]
3. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
4. TIGAR inclusion pathology is specific for Lewy body diseases.
López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR
Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647
[TBL] [Abstract][Full Text] [Related]
5. The impact of pathogenic mitochondrial DNA mutations on substantia nigra neurons.
Reeve A; Meagher M; Lax N; Simcox E; Hepplewhite P; Jaros E; Turnbull D
J Neurosci; 2013 Jun; 33(26):10790-801. PubMed ID: 23804100
[TBL] [Abstract][Full Text] [Related]
6. Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease.
Dijkstra AA; Voorn P; Berendse HW; Groenewegen HJ; ; Rozemuller AJ; van de Berg WD
Mov Disord; 2014 Sep; 29(10):1244-51. PubMed ID: 24996051
[TBL] [Abstract][Full Text] [Related]
7. Early Forms of
Flønes IH; Nyland H; Sandnes DA; Alves GW; Tysnes OB; Tzoulis C
Biomolecules; 2022 May; 12(6):. PubMed ID: 35740871
[TBL] [Abstract][Full Text] [Related]
8. The nigro-striatal and nigro-amygdaloid pathways undergo different degeneration processes in brains of dementia with Lewy bodies.
Iseki E; Marui W; Yamamoto R; Togo T; Katsuse O; Kato M; Iwatsubo T; Kosaka K; Arai H
Neurosci Lett; 2005 May 20-27; 380(1-2):161-5. PubMed ID: 15854770
[TBL] [Abstract][Full Text] [Related]
9. Fragmentation of Golgi apparatus of nigral neurons with alpha-synuclein-positive inclusions in patients with Parkinson's disease.
Fujita Y; Ohama E; Takatama M; Al-Sarraj S; Okamoto K
Acta Neuropathol; 2006 Sep; 112(3):261-5. PubMed ID: 16855830
[TBL] [Abstract][Full Text] [Related]
10. A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death.
Greffard S; Verny M; Bonnet AM; Seilhean D; Hauw JJ; Duyckaerts C
Neurobiol Aging; 2010 Jan; 31(1):99-103. PubMed ID: 18457903
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
[TBL] [Abstract][Full Text] [Related]
12. CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease.
Galiano-Landeira J; Torra A; Vila M; Bové J
Brain; 2020 Dec; 143(12):3717-3733. PubMed ID: 33118032
[TBL] [Abstract][Full Text] [Related]
13. Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease.
Ferrer I; Martinez A; Blanco R; Dalfó E; Carmona M
J Neural Transm (Vienna); 2011 May; 118(5):821-39. PubMed ID: 20862500
[TBL] [Abstract][Full Text] [Related]
14. AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson's disease.
Ip CW; Klaus LC; Karikari AA; Visanji NP; Brotchie JM; Lang AE; Volkmann J; Koprich JB
Acta Neuropathol Commun; 2017 Feb; 5(1):11. PubMed ID: 28143577
[TBL] [Abstract][Full Text] [Related]
15. Early alpha-synuclein lipoxidation in neocortex in Lewy body diseases.
Dalfó E; Ferrer I
Neurobiol Aging; 2008 Mar; 29(3):408-17. PubMed ID: 17166629
[TBL] [Abstract][Full Text] [Related]
16. rAAV2/7 vector-mediated overexpression of alpha-synuclein in mouse substantia nigra induces protein aggregation and progressive dose-dependent neurodegeneration.
Oliveras-Salvá M; Van der Perren A; Casadei N; Stroobants S; Nuber S; D'Hooge R; Van den Haute C; Baekelandt V
Mol Neurodegener; 2013 Nov; 8():44. PubMed ID: 24267638
[TBL] [Abstract][Full Text] [Related]
17. Neuronal complex I deficiency occurs throughout the Parkinson's disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage.
Flønes IH; Fernandez-Vizarra E; Lykouri M; Brakedal B; Skeie GO; Miletic H; Lilleng PK; Alves G; Tysnes OB; Haugarvoll K; Dölle C; Zeviani M; Tzoulis C
Acta Neuropathol; 2018 Mar; 135(3):409-425. PubMed ID: 29270838
[TBL] [Abstract][Full Text] [Related]
18. Lewy Bodies and the Mechanisms of Neuronal Cell Death in Parkinson's Disease and Dementia with Lewy Bodies.
Power JH; Barnes OL; Chegini F
Brain Pathol; 2017 Jan; 27(1):3-12. PubMed ID: 26667592
[TBL] [Abstract][Full Text] [Related]
19. Neurogranin binds α-synuclein in the human superior temporal cortex and interaction is decreased in Parkinson's disease.
Koob AO; Shaked GM; Bender A; Bisquertt A; Rockenstein E; Masliah E
Brain Res; 2014 Dec; 1591():102-10. PubMed ID: 25446004
[TBL] [Abstract][Full Text] [Related]
20. Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of alpha-synuclein in mouse substantia nigra.
St Martin JL; Klucken J; Outeiro TF; Nguyen P; Keller-McGandy C; Cantuti-Castelvetri I; Grammatopoulos TN; Standaert DG; Hyman BT; McLean PJ
J Neurochem; 2007 Mar; 100(6):1449-57. PubMed ID: 17241127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
